Pharma Whistleblower Reveals Who Really Runs American Healthcare

Who really runs American healthcare? The answer is not your doctor. In this explosive interview, Dr. Mark Hyman is joined by pharma whistleblower Brigham Buhler, a former drug rep turned healthcare entrepreneur who pulls back the curtain on a system designed for profit, not your health. Together, they expose how "corporate capture" of our regulatory agencies like the FDA and hidden financial deals between insurance companies, their Pharmacy Benefit Managers (PBMs), and Big Pharma have created a system that profits from chronic disease. You'll learn the secrets the industry doesn't want you to know. In this episode, we discuss: The PBM Shell Game: Uncover the role of Pharmacy Benefit Managers (PBMs) in driving up drug prices for medications like insulin and opioids through secret rebates that benefit the insurance companies. Corporate Capture & The Revolving Door: Learn how the FDA’s revolving door with industry executives contributed to the opioid crisis and is now being used to suppress access to beneficial compounds like peptides. The Profitability of Sickness: Understand why insurance companies are incentivized to deny claims and keep you on expensive prescription drugs, rather than paying for preventative care or cures. The Illusion of a Free Market: Discover how corporations mislead the American people, block transparency, and limit your choices to protect their revenue streams. Empowering Yourself: Find out why you must take sovereignty over your own health and what you can do to navigate a system not built to support your well-being. This conversation is more than just an exposé; it’s a blueprint for taking back control. Learn how to become your own health advocate and join the movement to reclaim American healthcare for the people, not the profiteers #Healthcare #BigPharma #DrHyman #CorporateCapture #HealthInsurance #FunctionalMedicine #PharmaWhistleblower View Show Notes From This Episode Get Free Weekly Health Tips from Dr. Hyman https://drhyman.com/pages/picks?utm_c... Sign Up for Dr. Hyman’s Weekly Longevity Journal https://drhyman.com/pages/longevity?u... Join the 10-Day Detox to Reset Your Health https://drhyman.com/pages/10-day-detox Join the Hyman Hive for Expert Support and Real Results https://drhyman.com/pages/hyman-hive This episode is brought to you by Seed, BON CHARGE, Paleovalley, PerfectAmino and Big Bold Health. Visit seed.com/hyman and use code 25HYMAN for 25% off your first month of Seed's DS-01® Daily Synbiotic. Head to boncharge.com and use code DRMARK for 15% off your order. Get nutrient-dense, whole foods. Head to paleovalley.com/hyman for 15% off your first purchase. Go to bodyhealth.com and use code HYMAN20 for 20% off your first order. Get 30% off HTB Immune Energy Chews at bigboldhealth.com and use code DRMARK30 (0:00) Brigham Buhler on exposing the pharmaceutical industry's broken incentives (1:19) The paradox of the U.S. healthcare system and influence of corporate interests (3:40) Brigham Buhler's insights as a former pharmaceutical rep (5:06) Corporate capture's impact on chronic disease and the opioid crisis (12:31) Misaligned incentives in healthcare: insurance companies and PBMs (19:01) Healthcare inefficiencies and the opaque billing system (24:00) Proactive, personalized healthcare and solutions for misaligned incentives (30:08) Insurance approvals and economic incentives for patient health (35:08) Food companies' influence on health and legislative momentum for policy change (43:01) The illusion of a free market in healthcare and food industries (45:45) Front-of-package labeling and the true cost of food (49:02) Challenges with pharmaceutical pricing and FDA approvals (53:43) Regulation and optimism for the future of peptides (1:00:48) FDA controversies and incentivizing health over disease (1:04:41) Government and FTC actions on health and food policies (1:06:11) Change with new administration and impact of consumer actions (1:09:07) The role of grassroots advocacy and historical change (1:10:38) Chronic disease as a unifying issue and closing remarks